JPMorgan Chase & Co’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-134
| Closed | -$1.53K | – | 6852 |
|
|
2023
Q4 | $1.53K | Hold |
134
| – | – | ﹤0.01% | 5730 |
|
|
2023
Q3 | $557 | Sell |
134
-2
| -1% | -$8 | ﹤0.01% | 5753 |
|
|
2023
Q2 | $968 | Sell |
136
-8
| -6% | -$57 | ﹤0.01% | 5554 |
|
|
2023
Q1 | $1K | Buy |
144
+8
| +6% | +$56 | ﹤0.01% | 5718 |
|
|
2022
Q4 | $1K | Sell |
136
-114
| -46% | -$838 | ﹤0.01% | 5522 |
|
|
2022
Q3 | $2K | Buy |
250
+71
| +40% | +$568 | ﹤0.01% | 5365 |
|
|
2022
Q2 | $3K | Sell |
179
-19,856
| -99% | -$333K | ﹤0.01% | 5392 |
|
|
2022
Q1 | $996K | Sell |
20,035
-409
| -2% | -$20.3K | ﹤0.01% | 3612 |
|
|
2021
Q4 | $1.54M | Sell |
20,444
-985
| -5% | -$74.4K | ﹤0.01% | 3376 |
|
|
2021
Q3 | $1.69M | Sell |
21,429
-1,403
| -6% | -$111K | ﹤0.01% | 3283 |
|
|
2021
Q2 | $3.17M | Sell |
22,832
-1,177
| -5% | -$163K | ﹤0.01% | 2935 |
|
|
2021
Q1 | $5.02M | Buy |
24,009
+15,499
| +182% | +$3.24M | ﹤0.01% | 2646 |
|
|
2020
Q4 | $1.41M | Buy |
8,510
+8,116
| +2,060% | +$1.35M | ﹤0.01% | 3179 |
|
|
2020
Q3 | $63K | Sell |
394
-393
| -50% | -$62.8K | ﹤0.01% | 4226 |
|
|
2020
Q2 | $130K | Buy |
787
+552
| +235% | +$91.2K | ﹤0.01% | 3857 |
|
|
2020
Q1 | $27K | Sell |
235
-3
| -1% | -$345 | ﹤0.01% | 4294 |
|
|
2019
Q4 | $35K | Hold |
238
| – | – | ﹤0.01% | 4333 |
|
|
2019
Q3 | $32K | Buy |
238
+75
| +46% | +$10.1K | ﹤0.01% | 4385 |
|
|
2019
Q2 | $20K | Buy |
163
+101
| +163% | +$12.4K | ﹤0.01% | 4524 |
|
|
2019
Q1 | $6K | Buy |
+62
| New | +$6K | ﹤0.01% | 4699 |
|